The Effectiveness of Modern Antihistamines for Treatment of Allergic Rhinitis – An IPD Meta-Analysis of 140,853 Patients doi:10.2332/allergolint.12-OA-0486 Background: Allergic rhinitis represents a worldwide health problem. The prevalence is increasing. The aim of this study was to analyse the correlation between the severity of allergic rhinitis and an adequate treatment dose of modern oral antihistamines. Methods: From a comprehensive databank containing data from ten different open-label prospective observational studies including raw data of 140,853 patients with allergic rhinitis, symptomatology variables were analysed and scored to study the effects of treatment with four antihistamines (Desloratadine, Ebastine, Fexofenadine, Levocetirizine) alone or in combination with intranasal corticosteroids. The patient data were collected in 23,606 study centres from Germany, mostly medical specialist and some primary care physicians in private practice. The analyses were performed via individual patient data meta-analysis techniques. Results: Finally 92,900 patient data from nine of ten studies could be analysed. One study with data of 47,953 patients was excluded due to incomplete treatment documentation. Both monotherapy analysis subgroups (Total Symptom Score and Total Nasal Symptom Score) were significantly better than those of their combinations with intranasal steroids. Monotherapy with levocetirizine was determined to be significantly more effective in lowering the Total Symptom Score (p < 0.001) and the Total Nasal Symptom Score (p < 0.05) than the other antihistamines. In the next stage, a greater positive effect of levocetirizine was demonstrated in relation to the severity of the clinical symptoms of allergic rhinitis (Total Nasal Symptom Score in cases with severe symptomatology [effect size = -0.09]). Conclusions: Levocetirizine asserted itself as the only antihistamine compared with the others as significant in this analysis. The study authors recommend monotherapy with the new-generation antihistamine levocetirizine, especially in severe cases of allergic rhinitis. KEY WORDS: allergic rhinitis, Desloratadine, Ebastine, Fexofenadine, Levocetirizine, treatment ABBREVIATIONS: TNSS, Total Nasal Symptom Score; TOSS,Total Ocular Symptom Score; TSS, Total Symptom Score; IPD, Individual Patient Data. Received: 30 July 2012. Accepted: 28 November 2012. Allergology International : In Press |
Friday, September 27, 2013
0 The Effectiveness of Modern Antihistamines for Treatment of Allergic Rhinitis
Sunday, September 22, 2013
New asthma treatment guidelines.(DRUGS, PREGNANCY, AND LACTATION): An article from: Internal Medicine News
This digital document is an article from Internal Medicine News, published by International Medical News Group on May 15, 2005. The length of the article is 835 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details
Title: New asthma treatment guidelines.(DRUGS, PREGNANCY, AND LACTATION)
Author:
List Price: $ 5.95
Price: $ 5.95
Information on Asthma from Gooasthma.info Choices including causes, symptoms, diagnosis, risks and treatment and with links to other useful resources.
New asthma treatment guidelines.(DRUGS, PREGNANCY, AND LACTATION): An article from: Internal Medicine News
Inhaled corticosteroids and fetal growth.: An article from: Internal Medicine News
This digital document is an article from Internal Medicine News, published by Thomson Gale on April 15, 2006. The length of the article is 823 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details
Title: Inhaled corticosteroids and fetal growth.
Author: Gideon Koren
Publication: Internal Med
List Price: $ 5.95
Price: $ 5.95
Information on Asthma from Gooasthma.info Choices including causes, symptoms, diagnosis, risks and treatment and with links to other useful resources.
Inhaled corticosteroids and fetal growth.: An article from: Internal Medicine News
More Corticosteroids Asthma Products
Orignal From: New asthma treatment guidelines.(DRUGS, PREGNANCY, AND LACTATION): An article from: Internal Medicine News
0 The Influence of the Time and Temperature of Heat Treatment on the Allergenicity of Egg White Proteins
Original Article | |||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||
Thursday, September 19, 2013
0 Acute treatment of anaphylaxis in children
Acute treatment of anaphylaxis in children
Traitement dâurgence de lâanaphylaxie chez les enfants
Abstract
Tuesday, September 17, 2013
0 A review on guidelines for management and treatment of common variable immunodeficiency
A review on guidelines for management and treatment of common variable immunodeficiency
Hassan Abolhassani1, Babak Torabi Sagvand1, Tahaamin Shokuhfar1, Babak Mirminachi1, Nima Rezaei1,2 and Asghar Aghamohammadi*1
Monday, September 16, 2013
0 Acute rhinosinusitis: New guidelines for diagnosis and treatment
Acute rhinosinusitis: New guidelines for diagnosis and treatment
Teeters, Jennifer ATC; Boles, Michelle; Ethier, Julie; Jenkins, Ambria; Curtis, L. Gail PA-C, MPAS
- Article as PDF (972 KB)
Article as EPUB- Print this Article
- Email To Colleague
- Add to My Favorites
- Export to Citation Manager
Alert Me When Cited- Request Permissions
0 Airway gene expression in COPD is dynamic with inhaled corticosteroid treatment and reflects biological pathways associated with disease activity
- Chronic obstructive pulmonary disease
- Original article
Airway gene expression in COPD is dynamic with inhaled corticosteroid treatment and reflects biological pathways associated with disease activity
Maarten van den Berge1,2,Â
Katrina Steiling3,Â
Wim Timens4,2,Â
Pieter S Hiemstra5,
Peter J Sterk6,Â
Irene H Heijink1,2,Â
Gang Liu3,Â
Yuriy O Alekseyev7,Â
Marc E Lenburg3,
Avrum Spira3,Â
Dirkje S Postma1,2
1Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
2GRIAC (Groningen Research Institute for Asthma and COPD), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
3Division of Computational Biomedicine, Department of medicine, Boston University School of Medicine, Boston, Massachusetts, USA
4Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
5Department of Pulmonary Diseases, Leiden University Medical Center, Leiden, The Netherlands
6Department of Respiratory Medicine, F5-259, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
7Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts, USA
Correspondence toDr M van den Berge, Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Hanzeplein 1, Groningen 9700 RB, The Netherlands;m.van.den.berge@umcg.nl
Received 16 October 2012
Revised 4 June 2013
Accepted 30 June 2013
Published Online First 7 August 2013